TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,028 JPY | +0.12% |
|
-2.66% | -0.64% |
| 08:50am | Japanese Stocks End Little Changed After Three-Day Winning Streak on Inflation and Yen Woes | MT |
| 07:47am | Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas:
- sale of drugs and consumer care products;
- services.
Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).
Sector
Pharmaceuticals
Calendar
22/06/2024
- Peripheral Nerve Society Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,028
JPY
Average target price
4,744
JPY
Spread / Average Target
+17.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.64% | 39.77B | |
| +51.93% | 798B | |
| +41.51% | 633B | |
| -5.10% | 356B | |
| +19.53% | 328B | |
| +10.12% | 304B | |
| +17.66% | 244B | |
| +3.39% | 227B | |
| +10.75% | 216B | |
| +6.84% | 166B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema
